{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/331115338",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1528863768"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#331115338",
  "code": "2B30.0",
  "source": "http://id.who.int/icd/entity/331115338",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/331115338/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/331115338/postcoordinationScale/hasSeverity",
      "axisName": "http://id.who.int/icd/schema/hasSeverity",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1409966790",
        "http://id.who.int/icd/release/11/2024-01/mms/896293199",
        "http://id.who.int/icd/release/11/2024-01/mms/1094217460",
        "http://id.who.int/icd/release/11/2024-01/mms/238069351"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/331115338/postcoordinationScale/hasAlternativeSeverity2",
      "axisName": "http://id.who.int/icd/schema/hasAlternativeSeverity2",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1863636238",
        "http://id.who.int/icd/release/11/2024-01/mms/885826145",
        "http://id.who.int/icd/release/11/2024-01/mms/1746207012",
        "http://id.who.int/icd/release/11/2024-01/mms/303697349"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Nodular lymphocyte predominant Hodgkin lymphoma"
  },
  "definition": {
    "@language": "en",
    "@value": "Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is characterised by a nodular, or a nodular and diffuse proliferation of scattered large neoplastic cells known as popcorn or lymphocyte predominant cells (LP cells) â€”formerly called L&H cells for lymphocytic and/or histiocytic Reed-Sternberg cell variants. At present an overlap between NLPHL and T-cell-rich large B-cell lymphoma cannot be excluded."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Nodular lymphocyte predominant Hodgkin lymphoma"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hodgkin disease with lymphocytic-histiocytic predominance"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "lymphocyte-rich Hodgkin lymphoma"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hodgkin disease with lymphocytic predominance"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hodgkin disease with nodular lymphocytic predominance"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hodgkin disease with diffuse lymphocytic predominance"
      }
    }
  ]
}